Sepsis Diagnosis Market
Report code - SRHL115 | Published On : NA | Status: Upcoming

Opportunities & Gaps in the Sepsis Diagnosis Market:  By Technology (Microbiology, Molecular Diagnostic, Immunoassay, and Biomarkers), By Type of Testing (Blood Culture Media, and Instruments), By Mode of Testing (Automated, Semi-Automated), By Site of Testing (Laboratory Based, Patient Bed Side (POC)), By Type of Sepsis (Pathogen) (Bacterial, Fungal), By Testing Facility (Hospitals, Clinics, and Others), By Region (North America, Western Europe, Asia-Pacific, Latin America, Rest of the World)

This report, from Stratview Research, studies the clinical diagnostics market - sepsis diagnosis over the trend period of 2014 to 2017 and forecast period of 2018 to 2025. The report provides detailed insights into the market dynamics to enable informed business decision making and growth strategy formulation based on the opportunities present in the market.

The Burning Questions This Report Will Answer:

  1. How crucial is it to get accurate and fast result if a patient is diagnosed or suspected with Sepsis?
  2. Are there any disruptive technology that might change the way Sepsis is diagnosed in hospitals?
  3. Who influences these tests? General Physician or emergency medicine or critical care or infectious disease specialist?
  4. Are these tests covered under health insurance?

The Global Clinical Diagnostics Market – Sepsis Diagnosis: Highlights

Medically, sepsis is defined as the condition arising when the host or patient’s response to infection causes organ dysfunction in the host or patient, remains a major killer. Surprisingly, sepsis appears like a Cinderella condition, and in many countries especially the growing economies where the public awareness is low or negligible. In counties such as Germany (the administrative home of the Global Sepsis Alliance and World Sepsis Day), 49.0% of people surveyed had heard the word “sepsis”; in Brazil, that number was 6.6%.

With an aging population, both the incidence and case fatality rate of sepsis will increase further, making data critical for healthcare planning. Let us be aware that there are no specific treatments for sepsis, and improved awareness among policy makers and funding agencies may provide the impetus to take sepsis seriously, hence correct and timely diagnosis of Sepsis is imperative.

BioMérieux (France), Danaher (US), Becton, Dickinson and Company (US), Roche (Switzerland), and Abbott (US) are some of the big names in the sepsis diagnostic space. New players specially from China are already disrupting the monopoly enjoyed by these players.

Research Methodology

Our reports offer high-quality insights and are the outcome of detailed research methodology comprising extensive secondary research, rigorous primary interviews with industry stakeholders and validation and triangulation with Stratview Research’s internal database and statistical tools. More than 1,000 authenticated secondary sources, such as company annual reports, fact book, press release, journals, investor presentation, white papers, patents, and articles have been leveraged to gather the data. About 10 detailed primary interviews with the market players across the value chain in all four regions and industry experts have been executed to obtain both the qualitative and quantitative insights.

Report Features

This report provides market intelligence in the most comprehensive way. The report structure has been kept such that it offers maximum business value. It provides critical insights into the market dynamics and will enable strategic decision making for the existing market players as well as those willing to enter the market. The following are the key features of the report:

  • Market structure: Overview, industry life cycle analysis, supply chain analysis
  • Market environment analysis: Growth drivers and constraints, Porter’s five forces analysis, SWOT analysis
  • Market trend and forecast analysis
  • Market segment trend and forecast
  • Competitive landscape and dynamics: Market share, Product portfolio, New launches, etc.
  • Attractive market segments and associated growth opportunities
  • Emerging trends
  • Strategic growth opportunities for the existing and new players
  • Key success factors 
  • Future outlook

The global clinical diagnostics market (sepsis diagnostics) is segmented into the following categories: 

By Technology

  • Microbiology, Molecular Diagnostic, Immunoassay, Biomarkers

By Type of Testing

  • Blood Culture Media, Instruments,

By Mode of Testing

  • Automated, Semi-Automated,

By Site of Testing

  • Laboratory Based, Patient Bed Side (POC)

By Type of Sepsis (Pathogen)

  • Bacterial Sepsis, Fungal Sepsis

By Prevalence

  • Adults, children, neonatal, geriatric

By Testing Facility

  • Hospital Laboratories, Diagnostic Clinics, Research laboratories, Home Based Collection

By Region

  • North America (Country Analysis: the USA, Canada)
  • Western Europe (Country Analysis: Germany, France, the UK)
  • Asia-Pacific (Country Analysis: China, Japan, India, and Rest of Asia-Pacific)
  • Latin America (Country Analysis: Brazil, Argentina, Mexico, and Others)
  • Rest of the World (Sub-Region Analysis: The Middle East, Africa, Rest of Europe and Others) 

Report Customization Options

With this detailed report, Stratview Research offers one of the following free customization options to our first-time clients:

Company Profiling

  • SWOT analysis of key players (up to 3 players)
  • Benchmarking of key players on the following parameters: Product portfolio, geographical reach, regional presence, and strategic alliances

Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at

By clicking Submit button you accept our terms and conditions

Related Reports

Looking for Customized Report?

By clicking Submit button you accept our terms and conditions

Our Clients

Call Us : +1-313-307-4176